Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., specializes in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, benefiting from the pet economy and the depreciation of the RMB [2][3]. Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. was established on November 15, 1982, and went public on January 22, 2025. It is recognized as a national key high-tech enterprise [7]. - The company's main business revenue composition includes: medical ultrasound 50.32%, industrial ultrasound 19.04%, X-ray 16.30%, accessories 12.52%, and others 1.82% [7]. Financial Performance - For the period from January to March 2025, the company achieved operating revenue of 98.43 million, representing a year-on-year growth of 28.69%, and a net profit attributable to shareholders of 39.32 million, with a year-on-year increase of 47.70% [8]. - As of March 31, 2025, the company had a total of 26,800 shareholders, a decrease of 46.67% from the previous period, with an average of 2,047 circulating shares per person, an increase of 87.50% [8]. Market Position and Trends - The company participated in the 97th WVC annual meeting, showcasing its innovative veterinary medical imaging achievements and engaging with industry experts [2]. - The company has a significant overseas revenue share of 55.26%, benefiting from the depreciation of the RMB [3]. Technical Analysis - The average trading cost of the company's shares is 28.01, with the current stock price near a support level of 28.08, indicating potential for a rebound if the support level holds [6].
超研股份跌0.70%，成交额2.24亿元，近5日主力净流入-4787.67万